A company that makes things from a plant called cannabis had a good three months. They made more money than they spent and have been doing this for seven times in a row. The company is called Rubicon Organics and it works in Canada, where cannabis is legal. They are doing well because they make good products that people want to buy. In April 2024, there will be a big meeting where people who work with cannabis can talk about their businesses and learn from each other. This meeting is called the Benzinga Cannabis Capital Conference and it will be in Florida. Read from source...

1. The article is heavily biased towards Rubicon Organics and its positive cash flow and EBITDA, while ignoring other factors that might affect the company's performance, such as competitors, regulations, consumer preferences, etc.
2. The article uses exaggerated and inflated language to describe the company's achievements, such as "significant growth driver", "strong financial foundation", "trendsetting abilities", etc., without providing any evidence or data to support these claims.
3. The article promotes the Benzinga Cannabis Capital Conference as a must-attend event for the cannabis world, but does not disclose any potential conflicts of interest or sponsorship deals between Benzinga and Rubicon Organics or other cannabis companies.
4. The article contains several grammatical errors and inconsistencies in formatting, such as using "Benzinga Cannabis Capital Conference" and "bzcannabis.com" interchangeably, or switching from active to passive voice without explanation.

There is no one-size-fits-all answer to this question, as the best investment strategy for cannabis producers like Rubicon Organics depends on a variety of factors such as your risk tolerance, time horizon, personal preferences, and market conditions. However, some general guidelines that may help you make an informed decision are:

- Consider the financial performance and outlook of the company, including its revenue growth, profitability, cash flow, debt level, and valuation metrics such as price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value (EV)/EBITDA ratio. These indicators can give you a sense of how well the company is doing relative to its peers and the broader market, as well as how much room it has to grow in the future.